Publications by authors named "David Letzer"

Claim this Profile
I
Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease.
Connie A Haley, Marcos C Schechter, David Ashkin, Charles A Peloquin, J Peter Cegielski, David M Letzer

Clin Infect Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to: Toxoplasmosis Outbreak Associated With Toxoplasma gondii-Contaminated Venison-High Attack Rate, Unusual Clinical Presentation, and Atypical Genotype.
Amy C Schumacher, Lina I Elbadawi, Traci DeSalvo, Anne Straily, Daniel Ajzenberg, David Letzer

Clin Infect Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxoplasmosis Outbreak Associated With Toxoplasma gondii-Contaminated Venison-High Attack Rate, Unusual Clinical Presentation, and Atypical Genotype.
Amy C Schumacher, Lina I Elbadawi, Traci DeSalvo, Anne Straily, Daniel Ajzenberg, David Letzer

Clin Infect Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate impact of healthcare-facility-onset Clostridium difficile laboratory-identified events reporting methodology change on standardized infection ratios.
Carlos E Figueroa Castro, Louis Palen, Carrie Johnson, Mary Beth Graham, David Letzer

Infect Control Hosp Epidemiol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
:
: Clinical Experience of an Academic Health System in Southeastern Wisconsin.
Carlos E Figueroa Castro, Carrie Johnson, Mary Williams, April VanDerSlik, Mary Beth Graham, David Letzer

Open Forum Infect Dis· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis